Overview Safety Study of ME-609 for Treatment of Herpes Simplex Labialis in Adolescents Status: Completed Trial end date: 2007-09-01 Target enrollment: Participant gender: Summary The Purpose of this study is to evaluate the safety of ME-609 for the treatment of recurrent herpes labialis in adolescents. Phase: Phase 3 Details Lead Sponsor: Medivir